Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Samer Al Hadidi

Concepts (183)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
2934
7.390
Why?
Hematologic Neoplasms
6
2025
99
3.140
Why?
Immunotherapy, Adoptive
10
2025
159
3.050
Why?
Antibodies, Bispecific
5
2024
71
2.790
Why?
Hematopoietic Stem Cell Transplantation
7
2024
556
2.770
Why?
Hematology
3
2024
26
2.600
Why?
Medical Oncology
6
2024
96
2.510
Why?
Clinical Trials as Topic
7
2025
468
2.480
Why?
Neoplasms
8
2024
1233
2.440
Why?
Hodgkin Disease
3
2021
45
2.100
Why?
Drug Approval
5
2024
47
1.950
Why?
Neoplasm Recurrence, Local
6
2024
630
1.920
Why?
Humans
73
2025
50201
1.900
Why?
Neutropenia
2
2023
114
1.580
Why?
Waldenstrom Macroglobulinemia
2
2022
40
1.530
Why?
Physicians
3
2024
229
1.510
Why?
Transplantation, Autologous
7
2024
463
1.440
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1000
1.300
Why?
T-Lymphocytes
6
2024
329
1.290
Why?
Neoplasms, Second Primary
2
2024
74
1.090
Why?
Neoplasms, Plasma Cell
2
2024
37
1.060
Why?
Cross-Sectional Studies
8
2024
1580
1.040
Why?
United States Food and Drug Administration
6
2024
91
1.010
Why?
United States
14
2025
4898
0.990
Why?
Receptors, G-Protein-Coupled
2
2024
54
0.950
Why?
Terminology as Topic
2
2025
64
0.930
Why?
Authorship
1
2024
12
0.920
Why?
Autoimmune Diseases
1
2025
81
0.910
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.880
Why?
Antibodies, Monoclonal, Humanized
3
2023
224
0.870
Why?
Awards and Prizes
1
2023
18
0.840
Why?
Fractures, Spontaneous
1
2022
14
0.820
Why?
Tomography, X-Ray Computed
3
2017
1160
0.810
Why?
Periodicals as Topic
1
2022
57
0.790
Why?
Thalidomide
1
2024
374
0.790
Why?
Lymphoma, B-Cell
1
2022
61
0.770
Why?
Patient Participation
1
2022
67
0.750
Why?
Bone Diseases
1
2022
97
0.750
Why?
Venous Thromboembolism
1
2022
67
0.750
Why?
Practice Guidelines as Topic
2
2025
459
0.750
Why?
Brain Diseases
1
2021
80
0.730
Why?
Antibodies, Monoclonal
3
2024
459
0.730
Why?
Programmed Cell Death 1 Receptor
1
2020
40
0.710
Why?
Racism
1
2021
57
0.680
Why?
Atrial Fibrillation
1
2022
182
0.670
Why?
Quality of Life
2
2022
843
0.640
Why?
Healthcare Disparities
1
2022
279
0.630
Why?
Receptors, Antigen, T-Cell
3
2024
50
0.630
Why?
Platinum Compounds
1
2018
11
0.610
Why?
Mycosis Fungoides
1
2018
28
0.600
Why?
Subclavian Artery
1
2017
19
0.590
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2017
7
0.590
Why?
Pregnancy Complications, Neoplastic
1
2018
24
0.590
Why?
Antithrombin III Deficiency
1
2017
3
0.580
Why?
Pruritus
1
2018
44
0.580
Why?
Ulcer
1
2017
23
0.570
Why?
Lymphoproliferative Disorders
1
2017
26
0.570
Why?
Tachycardia, Ventricular
1
2017
43
0.570
Why?
Epstein-Barr Virus Infections
1
2017
29
0.570
Why?
Female
14
2025
26829
0.560
Why?
Combined Modality Therapy
4
2024
639
0.560
Why?
Abdominal Pain
1
2017
84
0.560
Why?
Colon
1
2017
96
0.550
Why?
Thromboembolism
1
2017
54
0.550
Why?
Deglutition Disorders
1
2017
75
0.550
Why?
Diagnosis, Differential
5
2018
1041
0.530
Why?
Dexamethasone
3
2024
434
0.530
Why?
Gangrene
1
2016
14
0.520
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
154
0.520
Why?
Immunosuppressive Agents
1
2017
226
0.510
Why?
Penile Diseases
1
2016
16
0.510
Why?
Adult
10
2025
13486
0.510
Why?
Aspirin
1
2016
111
0.500
Why?
Leiomyoma
1
2015
25
0.490
Why?
Migraine with Aura
1
2014
4
0.480
Why?
Hysterectomy
1
2015
88
0.480
Why?
Edema
1
2015
68
0.470
Why?
Early Diagnosis
1
2014
88
0.470
Why?
Carotid Stenosis
1
2014
64
0.460
Why?
Ovarian Neoplasms
1
2018
450
0.450
Why?
Brain Ischemia
1
2014
157
0.430
Why?
Melphalan
3
2023
173
0.430
Why?
Skin Neoplasms
1
2018
487
0.410
Why?
Middle Aged
7
2025
12356
0.410
Why?
Renal Insufficiency, Chronic
1
2015
170
0.400
Why?
Monoclonal Gammopathy of Undetermined Significance
2
2023
112
0.390
Why?
Antineoplastic Agents
1
2020
1176
0.390
Why?
Lung Neoplasms
1
2018
601
0.390
Why?
Myeloid Differentiation Factor 88
2
2022
33
0.390
Why?
Treatment Outcome
5
2025
5203
0.360
Why?
B-Cell Maturation Antigen
4
2024
89
0.360
Why?
Randomized Controlled Trials as Topic
4
2023
553
0.350
Why?
Diabetes Mellitus, Type 2
1
2016
486
0.340
Why?
Stroke
1
2014
479
0.330
Why?
Prognosis
3
2024
1963
0.320
Why?
Male
7
2025
25572
0.320
Why?
Survival Analysis
2
2023
670
0.320
Why?
Breast Neoplasms
1
2018
1187
0.310
Why?
Conflict of Interest
2
2024
25
0.280
Why?
Pulmonary Emphysema
1
2017
24
0.280
Why?
Risk Factors
4
2023
3644
0.280
Why?
Drug Resistance, Neoplasm
2
2020
315
0.280
Why?
Tumor Microenvironment
3
2023
222
0.270
Why?
Mutation
2
2022
1288
0.260
Why?
Plasma Cells
2
2024
221
0.250
Why?
Syndrome
2
2021
239
0.250
Why?
Career Choice
2
2024
111
0.250
Why?
World Health Organization
1
2025
49
0.240
Why?
Phthalimides
1
2024
4
0.240
Why?
Piperidones
1
2024
5
0.230
Why?
Drug Industry
1
2024
38
0.230
Why?
Consensus
1
2025
158
0.230
Why?
Morpholines
1
2024
66
0.230
Why?
Adaptor Proteins, Signal Transducing
1
2024
197
0.220
Why?
Molecular Targeted Therapy
1
2024
121
0.210
Why?
Financing, Organized
1
2023
13
0.210
Why?
Societies, Medical
1
2024
177
0.210
Why?
Fellowships and Scholarships
1
2024
118
0.210
Why?
Neoplasm, Residual
2
2022
160
0.210
Why?
Health Facilities
1
2023
40
0.210
Why?
Certification
1
2022
49
0.200
Why?
Faculty
1
2022
72
0.200
Why?
Patients
1
2022
47
0.200
Why?
Geography
1
2022
61
0.200
Why?
Social Media
1
2024
98
0.200
Why?
Animals
4
2024
13141
0.200
Why?
Paraproteinemias
1
2022
72
0.200
Why?
Blood Coagulation
1
2022
58
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Immunotherapy
1
2024
235
0.200
Why?
Patient Selection
1
2023
254
0.190
Why?
Transplantation Conditioning
1
2022
82
0.190
Why?
Phenylalanine
1
2022
131
0.190
Why?
Research Design
1
2023
344
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
104
0.180
Why?
Pyrimidines
1
2022
192
0.180
Why?
Maintenance Chemotherapy
1
2020
49
0.180
Why?
Protein Kinase Inhibitors
1
2022
205
0.180
Why?
Health Status Disparities
1
2022
196
0.170
Why?
Pain
1
2022
373
0.170
Why?
Disease Progression
2
2023
821
0.170
Why?
Anticoagulants
1
2022
253
0.170
Why?
Minority Groups
1
2020
130
0.160
Why?
Aged
2
2024
9505
0.160
Why?
Follow-Up Studies
1
2024
2188
0.160
Why?
Chemotherapy, Adjuvant
1
2018
121
0.150
Why?
Prospective Studies
1
2023
2396
0.140
Why?
Vomiting
1
2017
73
0.140
Why?
Electrocardiography
1
2017
259
0.130
Why?
Weight Loss
1
2017
241
0.130
Why?
Carotid Artery, Internal
1
2014
23
0.120
Why?
Endarterectomy, Carotid
1
2014
62
0.120
Why?
Cerebral Angiography
1
2014
97
0.120
Why?
Lower Extremity
1
2015
92
0.110
Why?
Aged, 80 and over
1
2020
3158
0.100
Why?
Bone Marrow
2
2022
356
0.090
Why?
Pregnancy
1
2018
2609
0.090
Why?
Young Adult
1
2018
4052
0.080
Why?
Radiography, Thoracic
1
2017
65
0.070
Why?
Equipment and Supplies
1
2024
16
0.060
Why?
Marketing
1
2024
22
0.060
Why?
Disclosure
1
2024
38
0.060
Why?
Cystatin M
1
2024
19
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Antibodies
1
2024
151
0.050
Why?
Mice
2
2024
5673
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Chromosome Deletion
1
2023
140
0.050
Why?
In Situ Hybridization, Fluorescence
1
2023
256
0.050
Why?
Disease-Free Survival
1
2022
450
0.050
Why?
Pharmaceutical Preparations
1
2022
77
0.050
Why?
Bone Marrow Transplantation
1
2022
112
0.050
Why?
Chromosome Aberrations
1
2023
295
0.050
Why?
Proportional Hazards Models
1
2022
408
0.050
Why?
Genomics
1
2023
284
0.050
Why?
Stem Cell Transplantation
1
2022
179
0.050
Why?
Proteasome Inhibitors
1
2021
104
0.040
Why?
Cohort Studies
1
2023
1414
0.040
Why?
Cell Line, Tumor
1
2023
1390
0.040
Why?
Recurrence
1
2021
660
0.040
Why?
Gene Expression Profiling
1
2023
1029
0.040
Why?
Al Hadidi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description